ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .
We report common adverse events in 110 patients with suspected or probable SARS
Although information on efficacy and adverse drug reactions is lacking , ribavirin has been used empirically for the treatment of severe acute respiratory syndrome ( SARS ) .
We report common adverse events in 110 patients with suspected or probable SARS who were treated with ribavirin .